Navigation Links
Colleen Goggins, Worldwide Chairman, Consumer Group Plans Retirement From Johnson & Johnson in Early 2011
Date:9/16/2010

NEW BRUNSWICK, N.J., Sept. 16 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) said today that Colleen Goggins, 56, Worldwide Chairman, Consumer Group, has announced her retirement from the Company effective March 1, 2011, after a successful and distinguished career spanning almost 30 years.

William C. Weldon, Chairman and CEO, said, "Throughout her tenure, Colleen has demonstrated our commitment to our consumers and our people, and has made major contributions to our success.  We thank Colleen for her dedication and extraordinary service, and wish her all the best in the years to come."

Ms. Goggins joined Johnson & Johnson in 1981, working in various assignments of increasing responsibility.  She became President of Johnson & Johnson Canada in 1992; President, Personal Products Company, U.S. in 1994; and President, Johnson & Johnson Consumer Companies Inc. in 1995.  She was promoted to Company Group Chairman in 1998.  Colleen assumed her current position as a member of the Executive Committee in June 2001.

Mr. Weldon added: "Colleen is among the group of executives that have led the effort to formulate and implement the remediation plan regarding the quality issues at McNeil.  In light of Colleen's decision to retire, I am pleased that we have a clear remediation plan in place and we will work together to ensure a smooth transition of her responsibilities. We will make a timely announcement of succession plans for this critical position for the Company."


'/>"/>
SOURCE Johnson & Johnson
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Reportlinker Adds Portable and Transport Ventilator Market Shares, Strategies, and Forecasts, Worldwide, 2010 to 2016
2. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
3. TechniScan Announces Adding Another Center to Worldwide Clinical Trials for New Breast Imaging System
4. Pfizer Appoints Mikael Dolsten President of Worldwide Research and Development
5. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
6. Eye-Fi Expands Hotspot Access Service Worldwide
7. Orbitz Worldwide, Inc. to Host First Quarter 2010 Earnings Call on May 5
8. Best Practice Adopted Worldwide From Norway to Australia
9. Elekta VMAT Radiation Therapy Rapidly Gaining Users Worldwide as Technique Evolves
10. Cephalon Executive Vice President of Worldwide Pharmaceutical Operations Robert Roche to Resign Position
11. Derma Sciences Obtains Exclusive Worldwide Rights to MEDIHONEY(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 8, 2016 KEY FINDINGS ... of the market in 2016 and is expected to ... attributed to a large number of surgical procedures that ... largest share in the patient temperature management market.) Patient ... reducing loss of blood during surgeries, lowering the risks ...
(Date:12/8/2016)... Research and Markets has announced the addition ... Adhesion Type, Application, Usability - Forecast to 2025" report to ... , , ... poised to grow at a CAGR of around 3.2% from 2015 ... witnessing include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research ...
(Date:12/8/2016)... 2016  Valeant Pharmaceuticals International, Inc. (NYSE: ... announced positive results from a Phase 3, multicenter ... safety and efficacy of IDP-118 (halobetasol propionate and ... Within the Phase 3 study ... psoriasis, IDP-118 showed statistical significance to vehicle with ...
Breaking Medicine Technology:
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... whiteboard display solutions, proudly announced today that a new solution for Emergency Departments ... fit in the tight space in Emergency Department examination rooms, and with a ...
(Date:12/8/2016)... Cambridge, MA (PRWEB) , ... December 08, 2016 ... ... the Workers Compensation Research Institute (WCRI) officially opened registration today for its ... Place Hotel in Boston, MA . , The theme of the conference is ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s leading digital ... aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced CURE Media ... Jr said, “CURE Media Group is honored to team up with Upstage Lung Cancer ...
(Date:12/8/2016)... (PRWEB) , ... December 08, ... ... Presence Suite 10.2 version gives development continuity to its innovative Unified Instance ... channels management capacity. In addition, this new version optimizes the unattended auto-dialing ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are encouraged ... in mind, SIGVARIS has created a new line of anti-embolism stockings to help ... provide the benefits of graduated compression when transitioning from recovery to early rehabilitation. ...
Breaking Medicine News(10 mins):